Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
T cells、genetic manipulation、adoptive immunotherapy、chimeric antigen
8
R73;R39
a US National Institutes of Health NIHGrants YZ 2R01CA120409
2017-12-18(万方平台首次上网日期,不代表论文的发表时间)
共10页
634-643